Assessment of the association between visceral obesity and the progression of diabetic nephropathy
None
1. Patients age < 18 years. 2. BMI < 25 kg/m2 3. Nondiabetic patients 4. Patients with non-diabetic kidney disease. 5. Patients with AKI 6. Patients with CKD stage 5 either on dialysis or not.
Diabetic patients either type 1 or type 2 diabetes aged \> 18 years whether known to have diabetic nephropathy or not with BMI is ≥ 25 kg/m2
Case-crossover
Cross-sectional
Not listed
Assessment of the association between visceral obesity and the progression of diabetic nephropathy
Assessment of visceral obesity new measures as (the visceral adiposity index (VAI) , lipid accumulation product (LAP) , neck circumference (NC), waist-to-hip ratio (WHR) ) as a risk factor for the progression of diabetic nephropathy and poor renal outcome.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
